Reipet – Lifestyle
Author:
Orchestra BioMed Holdings, Inc.
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
April 30, 2026
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
April 23, 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026